EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial

Marwan El-Deyarbi iD, Luai Ahmed, Jeffrey King, Zelal S Adi, Ahmed Al Juboori, Nirmin A Mansour, Huda Al Nuaimi, Rami Beiram, Salahdein Aburuz iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0327211 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, 2025. Verfasst von Marwan El-Deyarbi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Life Style, Hypoglycemic Agents. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clinical evidence on the protective effects of a balanced diet, exercise, and medication adherence along with intensive glucose-lowering therapies on diabetes progression is lacking, and interventions that are most effective in slowing cardiorenal metabolic complications in patients with diabetes remain unelucidated.

Objective

To determine the effects of long-term multifactorial interventions on clinical outcomes in Emirati patients with diabetes attending ambulatory healthcare clinics.

Methods

We conducted a randomised controlled clinical trial at the Oud Al-Touba Clinic involving 192 participants with diabetes, who were blinded to the intervention and control groups, and followed up for 1 year. At the 3-, 6-, and 9-month visits, the intervention and control groups received multifactorial interventions and standard routine care, respectively. Glycated haemoglobin A1c (HbA1c) levels, estimated glomerular filtration rate (eGFR), blood pressure, electrolyte levels, and cardiovascular events were assessed at study completion.

Results

During a mean follow-up of 11.9 months, 40.4% of the participants in the intervention group (31.6% in the control group) achieved diabetes control (HbA1c < 7%), with a significant mean difference of −0.36% in HbA1c levels between the groups (95% CI: −0.54 – −0.19, P < 0.01). Participants in the multifactorial group achieved a significant mean difference in low-density lipoprotein cholesterol levels (mean difference = −0.14, 95% CI: −0.27–0.001, P < 0.03), and significant adjusted mean difference of eGFR levels difference (3.93 mL/min/1.73 m 2 , 95% CI: 1.27–6.58, P < 0.01) at study completion compared to those in the control group. Moreover, the percentage of participants in the intervention group who met the blood pressure target increased from 38.3% to 51.1%, accompanied with a decrease in serum electrolyte levels, compared to 34.7% to 36.7% in the control group at the end of the follow-up.

Conclusions

Implementing multifactorial interventions by a multidisciplinary team improved several clinical manifestations, including HbA1c, SBP, and eGFR, and decreased cardiovascular risk factors despite the decreased diabetes medication use.

Trial registration

ClinicalTrials.gov NCT04942119

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Life StyleHypoglycemic AgentsHumansFemaleMaleMiddle AgedGlycated HemoglobinAgedGlomerular Filtration RateBlood PressureAdult

Substanzen

Glycated HemoglobinHypoglycemic Agentshemoglobin A1c protein, human

Autor:innen und Institutionen

  • Department of Pharmacology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE.
  • Department of Pharmacy, Oud Al-Touba Diagnostic and Screening Clinic, Ambulatory Health Services, Abu Dhabi Health Services Co. (SEHA), Al Ain, UAE.
  • Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE.
  • David Geffen School of Medicine at the University of California, Los Angeles, California, United States of America.
  • Department of Geriatrics and Extended Care, VA Greater Los Angeles Healthcare System, U.S. Department of Veterans Affairs, Los Angeles, California, United States of America.
  • Division of Endocrinology, Oud Al-Touba Diagnostic and Screening Clinic, Ambulatory Health Services, Abu Dhabi Health Services Co. (SEHA), Al Ain, UAE.

ORCID-Profile: Marwan El-Deyarbi, Salahdein Aburuz

Zitieren

APA

El-Deyarbi, M., Ahmed, L., King, J., Adi, Z. S., Al Juboori, A., Mansour, N. A., Al Nuaimi, H., Beiram, R., & Aburuz, S. (2025). Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial. PLOS One. https://doi.org/10.1371/journal.pone.0327211

Vancouver

El-Deyarbi M, Ahmed L, King J, Adi ZS, Al Juboori A, Mansour NA, et al. Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial. PLOS One. 2025. doi:10.1371/journal.pone.0327211

BibTeX
@article{ElDeyarbi2025,
  author = {El-Deyarbi, Marwan and Ahmed, Luai and King, Jeffrey and Adi, Zelal S and Al Juboori, Ahmed and Mansour, Nirmin A and Al Nuaimi, Huda and Beiram, Rami and Aburuz, Salahdein},
  title = {Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0327211}
}
Kostenlos starten →